Literature DB >> 26337821

Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study.

Ying Yu1, Xia-Xi Li1, Ling-Xiao Jiang2, Meng Du1, Zhan-Guo Liu1, Zhong-Ran Cen1, Hua Wang1, Zhen-Hui Guo3, Ping Chang1.   

Abstract

BACKGROUND: Numerous investigations on procalcitonin (PCT) have been carried out, although few with large sample size. To deal with the complexity of sepsis, an understanding of PCT in heterogeneous clinical conditions is required.
METHODS: Hospitalized patients aged 10-79 years were included in this retrospective and cross-sectional study. PCT tests were assayed within 2 days of blood culture.
RESULTS: A total of 2952 cases (from 2538 patients) were enrolled in this study, including 440 cases in the 'positive BC' group, 123 cases in the 'positive body fluid culture' group, and 2389 cases in the 'negative all culture' group. Median PCT values were 4.53 ng/ml, 2.95 ng/ml, and 0.49 ng/ml, respectively. Median PCT values in the gram-negative BC group and gram-positive BC group, respectively, were 6.99 ng/ml and 2.96 ng/ml. Median PCT values in the 'positive hydrothorax culture' group, 'positive ascites culture' group, 'positive bile culture' group, and 'positive cerebrospinal fluid culture' group, respectively, were 1.39 ng/ml, 8.32 ng/ml, 5.98 ng/ml, and 0.46 ng/ml. In all, 357 cases were classified into the 'sepsis' group, 150 of them were classified into the 'severe sepsis' group. Median PCT values were 5.63 ng/ml and 11.06 ng/ml, respectively.
CONCLUSIONS: PCT could be used in clinical algorithms to diagnose positive infections and sepsis. Different PCT levels could be related to different kinds of microbemia, different infection sites, and differing severity of sepsis.

Entities:  

Keywords:  Procalcitonin; blood culture; body fluid culture; sepsis; severe sepsis

Mesh:

Substances:

Year:  2015        PMID: 26337821     DOI: 10.3109/23744235.2015.1082618

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  11 in total

Review 1.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

2.  Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.

Authors:  Yinzhi Leng; Caiyun Chen; Yongxiang Zhang; Can Luo; Bo Liu
Journal:  Ann Transl Med       Date:  2019-04

3.  The predictive value of procalcitonin combined with C-reactive protein and D dimer in moderately severe and severe acute pancreatitis.

Authors:  QiYong He; Jian Ding; ShanShan He; YunWen Yu; XiaoPing Chen; Dan Li; FengLin Chen
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-04-05       Impact factor: 2.586

Review 4.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

5.  Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections.

Authors:  Cheng Zheng; Jiachang Cai; Haizhou Liu; Shufang Zhang; Li Zhong; Nanxia Xuan; Hongwei Zhou; Kai Zhang; Yesong Wang; Xijiang Zhang; Baoping Tian; Zhaocai Zhang; Changming Wang; Wei Cui; Gensheng Zhang
Journal:  Infect Drug Resist       Date:  2019-10-31       Impact factor: 4.003

6.  Ultrasensitive Photochemical Immunosensor Based on Flowerlike SnO2/BiOI/Ag2S Composites for Detection of Procalcitonin.

Authors:  Nuo Zhang; Jinhui Feng; Guanhui Zhao; Xiaoyi Duan; Yaoguang Wang; Daopeng Zhang; Qin Wei
Journal:  Biosensors (Basel)       Date:  2021-10-28

7.  The Use of Serum Procalcitonin in the Setting of Infected Ureteral Stones: A Prospective Observational Study.

Authors:  Edward Capoccia; Patrick Whelan; Benjamin Sherer; Pete Tsambarlis; Wei Phin Tan; Alexander Chow; Michael Ryan Farrell; Brijesh Patel; Shaan Setia; Brittany M Wilson; Yanyu Zhang; Dimitri Papagiannopoulos
Journal:  J Endourol       Date:  2020-11-05       Impact factor: 2.619

8.  Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.

Authors:  Patrick Joseph; Eliot Godofsky
Journal:  Open Forum Infect Dis       Date:  2018-02-15       Impact factor: 3.835

Review 9.  Biomarkers of Infection: Are They Useful in the ICU?

Authors:  Eva Heilmann; Claudia Gregoriano; Philipp Schuetz
Journal:  Semin Respir Crit Care Med       Date:  2019-10-04       Impact factor: 3.119

10.  Nosocomial infection in China: Management status and solutions.

Authors:  Bingwei Sun
Journal:  Am J Infect Control       Date:  2016-04-07       Impact factor: 2.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.